USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
SPHYNKX THERAPEUTICS, LLC
Address:
1632 MEADOWBROOK HEIGHTS RD
CHARLOTTESVILLE, VA 22901-3001
Phone:
N/A
URL:
N/A
EIN:
127392886
DUNS:
965550804
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $469,659.00 2

Award List:

Improving in vivo stability of sphingosine kinase inhibitors

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$152,792.00
Agency:
HHS
Principal Investigator:
Steven B. Thorpe – 434-906-0275
Abstract:
DESCRIPTION (provided by applicant): We and others have hypothesized that inhibiting SphK1 is a powerful therapeutic strategy in pathologies that are characterized by cell hyperproliferation, e.g. cancer and fibrosis. This hypothesis was generated largelythrough the use interfering RNA strategies -… More

Phase II Commercialization of Continuous Countercurrent Tangential Chromatography

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$316,867.00
Agency:
HHS
Principal Investigator:
Steven B. Thorpe – 703-850-7206
Abstract:
DESCRIPTION: Vascular leak is a hallmark of tissue injury, and results in the movement of plasma into the interstitium where immune mediators and clotting factors invade the injured tissue. Left to persist, vascular leak can exacerbate inflammation and lead to a chronic and abnormal wound healing… More